{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_032409.3:c.731C>G",
          "cDNA Change": {
            "transcript": "NM_032409.3",
            "ref": "C",
            "alt": "G",
            "position": "731"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "G",
            "position": "244"
          },
          "Description in input context": "c.731C>G (p.A244G)"
        },
        {
          "HGVS": "NM_032409.3:c.949G>A",
          "cDNA Change": {
            "transcript": "NM_032409.3",
            "ref": "G",
            "alt": "A",
            "position": "949"
          },
          "Protein Change": {
            "ref": "V",
            "alt": "I",
            "position": "317"
          },
          "Description in input context": "c.949G>A (p.V317I)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal Recessive Parkinsonism",
    "MONDO": "MONDO:0000429"
  },
  "Experiment Method": [
    {
      "Assay Method": "TUNEL Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y neuroblastoma cells",
        "Description": "Human SH-SY5Y neuroblastoma cells were grown in 5% CO2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum containing penicillin (100 U/mL) and streptomycin (50 lg/mL)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.731C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Cells overexpressing PINK1 A244G showed no significant difference in cell viability compared to controls after staurosporine treatment, with TUNEL-positive cells at (33.3 ± 1.6)% vs. (36.0 ± 1.4)% in controls."
        },
        {
          "Variant": "NM_032409.3:c.949G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Cells overexpressing PINK1 V317I showed no significant difference in cell viability compared to controls after staurosporine treatment, with TUNEL-positive cells at (35.7 ± 1.6)% vs. (36.0 ± 1.4)% in controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The number of apoptotic cells was obtained counting TUNEL-positive cells in 10 random microscopic fields from different slides in each of three replicates."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Cells overexpressing wild-type PINK1 were used as a positive control, showing significantly lower levels of apoptosis compared to control cells."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells transfected with empty vector were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Statistical analysis was performed with SPSS software v. 12.0 using one-way analysis of variance and post hoc multiple comparisons with Bonferroni correction."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Apoptosis levels significantly lower than control cells after staurosporine treatment, e.g., TUNEL-positive cells < 30%.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Apoptosis levels similar to or higher than control cells after staurosporine treatment, e.g., TUNEL-positive cells ≥ 33%.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blotting Analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y neuroblastoma cells",
        "Description": "Human SH-SY5Y neuroblastoma cells were grown in 5% CO2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum containing penicillin (100 U/mL) and streptomycin (50 lg/mL)."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.731C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Western Blotting showed that activated caspase-3 levels were not reduced in PINK1 A244G cells compared to controls after staurosporine treatment."
        },
        {
          "Variant": "NM_032409.3:c.949G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Western Blotting showed that activated caspase-3 levels were not reduced in PINK1 V317I cells compared to controls after staurosporine treatment."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Cells overexpressing wild-type PINK1 were used as a positive control, showing reduced activated caspase-3 levels compared to control cells."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells transfected with empty vector were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Significant reduction in activated caspase-3 levels compared to control cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "No reduction in activated caspase-3 levels compared to control cells.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}